Al Charest
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Extracellular vesicles in disease 4
- Protein Tyrosine Phosphatases 2
- Protein Degradation and Inhibitors 2
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Jaime Acquaviva (2 shared papers)Ricky Ngok‐Shun Wong (1 shared paper)David E. Housman (3 shared papers)Roderick T. Bronson (5 shared papers)Ralph Weissleder (4 shared papers)Steve Woolfenden (4 shared papers)Haihao Zhu (3 shared papers)Eric C. Holland (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Cancer Research (2 papers)iScience (1 paper)Molecular Cancer Therapeutics (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesMexicoGermany
In The Last Decade
Al Charest
17 papers receiving 1.2k citations
Al Charest's Hit Papers
Peers
Comparison fields: 5 of 86
- Genetics 299
- Cancer Research 352
- Oncology 307
- Molecular Biology 761
- Immunology 202
Countries citing papers authored by Al Charest
This map shows the geographic impact of Al Charest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Al Charest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Al Charest more than expected).
Fields of papers citing papers by Al Charest
This network shows the impact of papers produced by Al Charest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Al Charest. The network helps show where Al Charest may publish in the future.
Co-authors
The 25 scholars most cited alongside Al Charest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 229 | |
| 2 | 2009 | 172 | |
| 3 | Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression Hit paper breakdown → | 2022 | 153 |
| 4 | 2008 | 151 | |
| 5 | 2006 | 120 | |
| 6 | 2016 | 81 | |
| 7 | 2011 | 74 | |
| 8 | 2019 | 54 | |
| 9 | 2009 | 46 | |
| 10 | 2014 | 29 | |
| 11 | 2010 | 28 | |
| 12 | 2009 | 16 | |
| 13 | 2021 | 16 | |
| 14 | 2023 | 15 | |
| 15 | 2020 | 11 | |
| 16 | 2018 | 5 | |
| 17 | 2019 | 1 | |
| 18 | 2023 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Al Charest
Al Charest is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Immunology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Glioma Diagnosis and Treatment (5 papers), MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Protein Tyrosine Phosphatases (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Genetics (299 citations), Cancer Research (352 citations), Oncology (307 citations), Molecular Biology (761 citations) and Immunology (202 citations). Al Charest has collaborated with scholars based in United States, Mexico and Germany. Frequent co-authors include Jaime Acquaviva, Ricky Ngok‐Shun Wong, David E. Housman, Roderick T. Bronson, Ralph Weissleder, Steve Woolfenden, Haihao Zhu, Eric C. Holland, Dolores Hambardzumyan and Luis F. Parada. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, iScience, Molecular Cancer Therapeutics and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.